Gut Microbiota Metabolites of Dietary Lignans and Risk of Type 2 Diabetes: A Prospective Investigation in Two Cohorts of U.S. Women. Diabetes Care 2014;37:1287–1295

A minor coding error occurred in the analysis programs that generated results included in the article cited above. In Table 1, the proportions of postmenopausal hormone use should be 61.3% (rather than 37.0%) for case subjects and 63.3% (rather than 35.4%) for control subjects in the Nurses’ Health Study (NHS). In Supplementary Table 2, the proportions of postmenopausal hormone use should be 70.2%, 64.0%, 55.9%, and 62.7% (rather than 29.8%, 33.3%, 43.8%, and 34.8%) in the 1st, 2nd, 3rd, and 4th quartiles of lignan metabolites in the NHS, respectively.

The online version reflects these changes.

• © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.